KRYSTAL-1: Activity and safety of adagrasib (MRTX849) in advanced/ metastatic non-small-cell lung cancer (NSCLC) harboring KRAS G12C mutation Meeting Abstract
| Authors: | Jänne, P. A.; Rybkin, I. I.; Spira, A. I.; Riely, G. J.; Papadopoulos, K. P.; Sabari, J. K.; Johnson, M. L.; Heist, R. S.; Bazhenova, L.; Barve, M.; Pacheco, J. M.; Leal, T. A.; Velastegui, K.; Cornelius, C.; Olson, P.; Christensen, J. G.; Kheoh, T.; Chao, R. C.; Ou, S. H. I. |
| Abstract Title: | KRYSTAL-1: Activity and safety of adagrasib (MRTX849) in advanced/ metastatic non-small-cell lung cancer (NSCLC) harboring KRAS G12C mutation |
| Meeting Title: | 32nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics |
| Journal Title: | European Journal of Cancer |
| Volume: | 138 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2020 Oct 24-25 |
| Meeting Location: | Virtual |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2020-10-01 |
| Start Page: | S1 |
| End Page: | S2 |
| Language: | English |
| ACCESSION: | WOS:000582839900004 |
| PROVIDER: | wos |
| DOI: | 10.1016/s0959-8049(20)31076-5 |
| Notes: | Meeting abstract: 3LBA -- Source: Wos |
